Nasdaq
BBOT
BridgeBio Oncology Therapeutics, Inc.
- Health Care
- Listed 2024
- 1 day
- −2.0%
- 1 month
- +5.9%
- 1 year
- −11.2%
$8.78 · Mkt cap $703M
At the 6 Aug 2026 close
Nasdaq
BridgeBio Oncology Therapeutics, Inc.
$8.78 · Mkt cap $703M
At the 6 Aug 2026 close
BridgeBio Oncology Therapeutics, Inc. trades under the ticker BBOT on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2024. Its market capitalisation is $703M. The last closing price was $8.78, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −11.2%, and +5.9% over the past month. Returns are price returns and exclude dividends.
This page exists because BBOT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.